Literature DB >> 16278970

Sacred disease secrets revealed: the genetics of human epilepsy.

Julie Turnbull1, Hannes Lohi, Jennifer A Kearney, Guy A Rouleau, Antonio V Delgado-Escueta, Miriam H Meisler, Patrick Cossette, Berge A Minassian.   

Abstract

Neurons throughout the brain suddenly discharging synchronously and recurrently cause primarily generalized seizures. Discharges localized awhile in one part of the brain cause focal-onset seizures. A genetically determined generalized hyperexcitability had been predicted in primarily generalized seizures, but surprisingly the first epilepsy gene discovered, CHRNA4, was in a focal (frontal lobe)-onset syndrome. Another surprise with CHRNA4 was its encoding of an ion channel present throughout the brain. The reason why CHRNA4 causes focal-onset seizures is unknown. Recently, the second focal (temporal lobe)-onset epilepsy gene, LGI1 (unknown function), was discovered. CHRNA4 led the way to mutation identifications in 15 ion channel genes, most causing primarily generalized epilepsies. Potassium channel mutations cause benign familial neonatal convulsions. Sodium channel mutations cause generalized epilepsy with febrile seizures plus or, if more severe, severe myoclonic epilepsy of infancy. Chloride and calcium channel mutations are found in rare families with the common syndromes childhood absence epilepsy and juvenile myoclonic epilepsy (JME). Mutations in the EFHC1 gene (unknown function) occur in other rare JME families, and yet in other families, associations are present between JME (or other generalized epilepsies) and single nucleotide polymorphisms in the BRD2 gene (unknown function) and the malic enzyme 2 (ME2) gene. Hippocrates predicted the genetic nature of the 'sacred' disease. Genes underlying the 'malevolent' forces seizing 1% of humans have now been revealed. These, however, still account for a mere fraction of the genetic contribution to epilepsy. Exciting years are ahead, in which the genetics of this extremely common, and debilitating, neurological disorder will be solved.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16278970

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  10 in total

1.  Mutations in the CLCN2 gene are a rare cause of idiopathic generalized epilepsy syndromes.

Authors:  E Stogmann; P Lichtner; C Baumgartner; M Schmied; C Hotzy; F Asmus; F Leutmezer; S Bonelli; E Assem-Hilger; K Vass; K Hatala; T M Strom; T Meitinger; F Zimprich; A Zimprich
Journal:  Neurogenetics       Date:  2006-08-24       Impact factor: 2.660

2.  Recessive loss-of-function mutation in the pacemaker HCN2 channel causing increased neuronal excitability in a patient with idiopathic generalized epilepsy.

Authors:  Jacopo C DiFrancesco; Andrea Barbuti; Raffaella Milanesi; Stefania Coco; Annalisa Bucchi; Georgia Bottelli; Carlo Ferrarese; Silvana Franceschetti; Benedetta Terragni; Mirko Baruscotti; Dario DiFrancesco
Journal:  J Neurosci       Date:  2011-11-30       Impact factor: 6.167

3.  Voltage-gated potassium channel KCNV2 (Kv8.2) contributes to epilepsy susceptibility.

Authors:  Benjamin S Jorge; Courtney M Campbell; Alison R Miller; Elizabeth D Rutter; Christina A Gurnett; Carlos G Vanoye; Alfred L George; Jennifer A Kearney
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-14       Impact factor: 11.205

4.  God and genes in the caring professions: clinician and clergy perceptions of religion and genetics.

Authors:  Virginia L Bartlett; Rolanda L Johnson
Journal:  Am J Med Genet C Semin Med Genet       Date:  2009-02-15       Impact factor: 3.908

5.  Infantile spasms is associated with deletion of the MAGI2 gene on chromosome 7q11.23-q21.11.

Authors:  Christian R Marshall; Edwin J Young; Ariel M Pani; Mary-Louise Freckmann; Yves Lacassie; Cédric Howald; Kristi K Fitzgerald; Maarit Peippo; Colleen A Morris; Kate Shane; Manuela Priolo; Masafumi Morimoto; Ikuko Kondo; Esra Manguoglu; Sibel Berker-Karauzum; Patrick Edery; Holly H Hobart; Carolyn B Mervis; Orsetta Zuffardi; Alexandre Reymond; Paige Kaplan; May Tassabehji; Ronald G Gregg; Stephen W Scherer; Lucy R Osborne
Journal:  Am J Hum Genet       Date:  2008-06-19       Impact factor: 11.025

Review 6.  Mitochondria and reactive oxygen species.

Authors:  Francesco Addabbo; Monica Montagnani; Michael S Goligorsky
Journal:  Hypertension       Date:  2009-04-27       Impact factor: 10.190

7.  Time to seizure occurrence and damage in PROFILE, a multi-ethnic systemic lupus erythematosus cohort.

Authors:  R Ramsey-Goldman; G S Alarcón; G McGwin; M Petri; L M Vilá; J C Edberg; J D Reveille; R P Kimberly
Journal:  Lupus       Date:  2008-03       Impact factor: 2.911

8.  LGI2 truncation causes a remitting focal epilepsy in dogs.

Authors:  Eija H Seppälä; Tarja S Jokinen; Masaki Fukata; Yuko Fukata; Matthew T Webster; Elinor K Karlsson; Sami K Kilpinen; Frank Steffen; Elisabeth Dietschi; Tosso Leeb; Ranja Eklund; Xiaochu Zhao; Jennifer J Rilstone; Kerstin Lindblad-Toh; Berge A Minassian; Hannes Lohi
Journal:  PLoS Genet       Date:  2011-07-28       Impact factor: 5.917

9.  Nonsense-mediated mRNA decay and loss-of-function of the protein underlie the X-linked epilepsy associated with the W356× mutation in synapsin I.

Authors:  Maila Giannandrea; Fabrizia C Guarnieri; Niels H Gehring; Elena Monzani; Fabio Benfenati; Andreas E Kulozik; Flavia Valtorta
Journal:  PLoS One       Date:  2013-06-20       Impact factor: 3.240

10.  Mitochondrial DNA variant m.15218A > G in Finnish epilepsy patients who have maternal relatives with epilepsy, sensorineural hearing impairment or diabetes mellitus.

Authors:  Heidi K Soini; Jukka S Moilanen; Tiina Vilmi-Kerälä; Saara Finnilä; Kari Majamaa
Journal:  BMC Med Genet       Date:  2013-07-19       Impact factor: 2.103

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.